The Latest Breaking News from HC Wainwright

SoundHound AI's stock price is set up for a massive rally that could begin as soon as the Q3 earnings release in early November.

Plug Power is back in the spotlight with fresh leadership news.

Summit Therapeutics Inc (NASDAQ:SMMT) and Akeso said ivonescimab, a PD-1xVEGF bispecific antibody, can extend patients' lives for EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) progressed after EGFR-TKI treatment.

The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical science, new therapies are emerging that promise to transform patient care and redefine market leadership in these critical areas.

CoreWeave’s sharp pullback may be setting the stage for a powerful rebound, according to H.C. Wainwright.

CRWV is testing a Fibonacci retracement level on the charts after an upgrade from H.C. Wainwright and reports that Jane Street bought a 5.4% stake.

From industry leaders to pre-revenue innovators, see which well-known nuclear energy stocks had the best and worst earnings performances in Q2.

Archer Aviation's strong Q2 results, highlighted by its first UAE aircraft delivery and a strong balance sheet, reinforce its path to near-term revenue.

CoreWeave (NASDAQ:CRWV) shares tumbled on Wednesday after the AI-focused cloud computing provider posted mixed second-quarter results, highlighting surging revenue and backlog alongside margin pressures from an aggressive expansion plan.